VIVS (VivoSim Labs, Inc. Common Stock) Stock Analysis - AI Report

VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of May 21, 2026, VIVS trades at $1.29 with a market cap of $3.68M and a P/E ratio of 0.00. VIVS moved +0.00% today. Year to date, VIVS is -33.33%; over the trailing twelve months it is -35.96%. Its 52-week range spans $1.25 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on VIVS?

Rallies AI research for VIVS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

VIVS Key Metrics

Key financial metrics for VIVS
MetricValue
Price$1.29
Market Cap$3.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.30
52-Week Low$1.25
Volume182.13K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest VIVS News

Recent VIVS Insider Trades

  • Gobel David bought 3.27K (~$7.30K) on Nov 17, 2025.

VIVS Analyst Consensus

VIVS analyst coverage data. Average price target: $0.00.

Common questions about VIVS

What is the AI research view on VIVS?
Rallies AI research for VIVS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for VIVS?
Rallies AI research for VIVS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is VIVS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VIVS. It does not provide personalized investment advice.
VIVS

VIVS